Billionaire Profile
Ye Xiaoping
Global Rank
#2340

Image: 侯波 | Public domain | via Wikimedia Commons

Ye Xiaoping

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$1.653B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
+0.94% (24h)
Age
63
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

Ye Xiaoping, at 63 years old, is the Chairman of Hangzhou Tigermed Consulting, a prominent contract research organization (CRO) in China's pharmaceutical industry, and is a self-made billionaire. His source of wealth stems from his involvement in the pharmaceutical sector. Ye's career includes over a decade of experience in medical and regulatory affairs within the global pharmaceutical industry. He holds an EMBA from Peking University and a Ph.D. from Oxford University. With a net worth of $1.8 billion, Ye Xiaoping has established himself as a key figure in the Chinese healthcare landscape, contributing to advancements in the pharmaceutical industry.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Ye Xiaoping's early life details are not widely available, but his educational background is well-documented. He holds an EMBA from Peking University's Guanghua School of Management and a Ph.D. from Oxford University. This strong academic foundation set the stage for his career in the pharmaceutical industry.

Rise to Success

Ye Xiaoping's rise to prominence came through his leadership at Hangzhou Tigermed Consulting. Before founding Tigermed, he gained over 10 years of experience in medical and regulatory affairs with global pharmaceutical industries and was the former medical director at Shanghai Roche for 6 years. Tigermed, founded in 2004, has become one of China's largest contract research organizations. This has played a significant role in his accumulation of wealth.

Key Business Strategies

Key to Ye Xiaoping's success has been his strategic vision for Tigermed. His leadership has focused on driving the development of the company's third-party independent audit business. He leverages his in-depth knowledge of the pharmaceutical industry to guide Tigermed's growth and expansion, making it a major player in the Chinese healthcare market.

Philanthropy

Details regarding Ye Xiaoping’s specific philanthropic initiatives and amounts are unavailable in the search results. Further research is needed to uncover his philanthropic activities.

Career Milestones

2004

Founded Tigermed

Ye Xiaoping co-founded Hangzhou Tigermed Consulting, a major contract research organization (CRO) in China.

Prior to 2004

Medical Director at Shanghai Roche

Ye served as medical director at Shanghai Roche for 6 years.

Philanthropy & Social Impact

Unknown

Unknown

$XB

Details regarding Ye Xiaoping’s specific philanthropic initiatives are unavailable.